lung cancer Archive — Page 9 of 16
-
May 30, 2017
Mix-and-match trial is actually precision medicine
-
May 30, 2017
Day In Life
-
January 12, 2017
Team’s discovery offers new insight on lung cancer risk
Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts. -
December 6, 2016
Sarcoma
-
December 6, 2016
An uptick in new drugs and clinical trials for sarcoma
-
December 6, 2016
Lisa Kachnic ushers in a new era for radiation oncology
-
October 20, 2016
VICC trial putting lung cancer therapy to the test
Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.